| Structure-based design of potent and selective ligands at the four adenosine receptors W Jespers, A Oliveira, R Prieto-Díaz, M Majellaro, J Åqvist, E Sotelo, ... Molecules 22 (11), 1945, 2017 | 37 | 2017 |
| 3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and … M Majellaro, W Jespers, A Crespo, MJ Núñez, S Novio, J Azuaje, ... Journal of Medicinal Chemistry 64 (1), 458-480, 2020 | 23 | 2020 |
| Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists A Mallo-Abreu, R Prieto-Díaz, W Jespers, J Azuaje, M Majellaro, ... Journal of Medicinal Chemistry 63 (14), 7721-7739, 2020 | 22 | 2020 |
| Catalytic performance of a metal-free graphene oxide-Al2O3 composite assembled by 3D printing J Azuaje, A Rama, A Mallo-Abreu, MG Boado, M Majellaro, CR Tubío, ... Journal of the European Ceramic Society 41 (2), 1399-1406, 2021 | 14 | 2021 |
| Multicomponent reaction-assisted drug discovery: a time-and cost-effective green approach speeding up identification and optimization of anticancer drugs G Graziano, A Stefanachi, M Contino, R Prieto-Díaz, A Ligresti, P Kumar, ... International Journal of Molecular Sciences 24 (7), 6581, 2023 | 12 | 2023 |
| Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition X Wang, W Jespers, R Prieto-Díaz, M Majellaro, AP IJzerman, ... Scientific Reports 11 (1), 14171, 2021 | 12 | 2021 |
| A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models AHM Tay, R Prieto-Díaz, S Neo, L Tong, X Chen, V Carannante, B Önfelt, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 11 | 2022 |
| Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists R Prieto-Díaz, M González-Gómez, H Fojo-Carballo, J Azuaje, ... Journal of Medicinal Chemistry 66 (1), 890-912, 2022 | 9 | 2022 |
| Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists D Miranda-Pastoriza, R Bernárdez, J Azuaje, R Prieto-Díaz, M Majellaro, ... ACS Medicinal Chemistry Letters 13 (2), 243-249, 2022 | 5 | 2022 |
| Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists C Val, C Rodríguez-García, R Prieto-Díaz, A Crespo, J Azuaje, ... Journal of Medicinal Chemistry 65 (3), 2091-2106, 2022 | 3 | 2022 |
| Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ … FS Abatematteo, M Majellaro, B Montsch, R Prieto-Díaz, M Niso, ... Journal of Medicinal Chemistry 66 (6), 3798-3817, 2023 | 1 | 2023 |
| Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal … R Prieto-Díaz, H Fojo-Carballo, M Majellaro, T Tandarić, J Azuaje, J Brea, ... Biomedicine & pharmacotherapy 173, 116345, 2024 | | 2024 |
| A2B Adenosine Receptor as a novel target in cancer immunotherapy: Validation and optimization of new ligands R Prieto Díaz University of Santiago de Compostela, 2023 | | 2023 |
Eddy Sotelo, ORCID: 0000-0001-5571...Full Professor of Medicinal Chemistry, CIQUS, Santiago de Compostela University.Verified email at usc.es
